RxSight, Inc.
NASDAQ:RXST
50.85 (USD) • At close November 7, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Revenue
| 89.077 | 49.005 | 22.593 | 14.678 | 2.241 |
| Cost of Revenue
| 35.312 | 27.677 | 18.076 | 12.973 | 4.06 |
| Gross Profit
| 53.765 | 21.328 | 4.517 | 1.705 | -1.819 |
| Gross Profit Ratio
| 0.604 | 0.435 | 0.2 | 0.116 | -0.812 |
| Reseach & Development Expenses
| 29.051 | 25.981 | 24.499 | 21.934 | 29.569 |
| General & Administrative Expenses
| 0 | 0 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 |
| SG&A
| 74.799 | 58.665 | 32.805 | 15.176 | 15.203 |
| Other Expenses
| -0.103 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 103.85 | 84.646 | 57.304 | 37.11 | 44.772 |
| Operating Income
| -50.085 | -63.318 | -52.787 | -35.405 | -46.07 |
| Operating Income Ratio
| -0.562 | -1.292 | -2.336 | -2.412 | -20.558 |
| Total Other Income Expenses Net
| 1.497 | -3.429 | 4.107 | 63.037 | 172.314 |
| Income Before Tax
| -48.588 | -66.747 | -48.68 | 27.632 | 126.244 |
| Income Before Tax Ratio
| -0.545 | -1.362 | -2.155 | 1.883 | 56.334 |
| Income Tax Expense
| 0.02 | 0.009 | 0.008 | 0.057 | 0.024 |
| Net Income
| -48.608 | -66.756 | -48.688 | 27.575 | 126.22 |
| Net Income Ratio
| -0.546 | -1.362 | -2.155 | 1.879 | 56.323 |
| EPS
| -1.41 | -2.41 | -1.78 | 0.12 | 0.95 |
| EPS Diluted
| -1.41 | -2.41 | -1.78 | 0.12 | 0.95 |
| EBITDA
| -45.842 | -61.801 | -52.733 | -30.85 | -40.354 |
| EBITDA Ratio
| -0.515 | -1.261 | -2.334 | -2.102 | -18.007 |